ImmuneBiotech is aimed to be a research and development company dedicated to find new ways to promote better health for patients with autoimmune disorders e.g. Multiple Sclerosis, Rheumatoid Arthritis and Type 1 Diabetes through pharmaceutical probiotic innovations. Considering the increased interest in bacterial food supplements, called probiotics, as potent inducers of anti-inflammatory responses and modulators of intestinal barrier integrity, we have developed a quite unique approach to treat autoimmune disorders by manipulating/stimulating the gut flora via oral administration of excessive lactobacilli with probiotic properties. The company aims to develop new and powerful therapeutic protocols, bacterial combinations or technologies for sale or royalty financing agreements.